By InvitationPhase 4

Quality Improvement and Practice Based Research in Neurology Using the EMR

United States3,300 participantsStarted 2016-05

Plain-language summary

The investigators will conduct at NorthShore University HealthSystem pragmatic trials using the EMR for 10 common neurological disorders. They will demonstrate the feasibility of subgroup based adaptive assignment of treatments, electronic consenting, and outcomes data capture at the point of care using the EMR. They will identify the most effective treatments for common neurological disorders and seek replication by the NPBRN.

Who can participate

Age range18 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of brain tumors, epilepsy, migraine, mild cognitive impairment (concussion), mild traumatic brain injury, multiple sclerosis, neuropathy, Parkinson's disease, restless legs syndrome, and stroke. * Eligible to receive any of the three compared treatments according to FDA approval for the indication or off label use according to standard of care. Exclusion Criteria: \-- None

What they're measuring

survival free of discontinuation or alternative prevention drug (migraine trial)

Timeframe: six months

survival free of disability measured by FAQ score 9+ (memory trial)

Timeframe: one year

survival free of discontinuation or alternative anti epileptic drug (epilepsy trial)

Timeframe: one year

Trial details

NCT IDNCT02670161

SponsorEndeavor Health

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12

View on ClinicalTrials.gov More Brain Tumors trials